Daniel N Swisher Jr's Net Worth
$10.8 Million
Estimate Recalculated Nov 7, 2024 11:44AM EST
Who is Daniel N Swisher Jr?
Daniel N Swisher Jr has an estimated net worth of $10.8 Million. This is based on reported shares across multiple companies, which include CORCEPT THERAPEUTICS INC, Jazz Pharmaceuticals plc, CERUS CORP, SUNESIS PHARMACEUTICALS INC, and Protagonist Therapeutics, Inc.
SEC CIK
Daniel N Swisher Jr's CIK is 0001323113
Past Insider Trading and Trends
2020 was Daniel N Swisher Jr's most active year for acquiring shares with 12 total transactions. Daniel N Swisher Jr's most active month to acquire stocks was the month of May. 2021 was Daniel N Swisher Jr's most active year for disposing of shares, totalling 17 transactions. Daniel N Swisher Jr's most active month to dispose stocks was the month of May. 2023 saw Daniel N Swisher Jr paying a total of $289,474.50 for 146,656 shares, this is the most they've acquired in one year. In 2023 Daniel N Swisher Jr cashed out on 31,826 shares for a total of $1,161,394.53, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CORCEPT THERAPEUTICS INC (CORT) Snapshot price: $34.38
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$19.34 | -$59,290.00 |
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
$18.04 | -$53,570.00 |
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
$14.48 | -$37,906.00 |
0
|
May 1
| |||
Form 4
|
—
|
0
|
$15.58 | -$42,768.00 |
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
$14.73 | -$39,006.00 |
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
$13.93 | -$35,508.00 |
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
$13.99 | -$35,750.00 |
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
$15.67 | -$43,142.00 |
0
|
Dec 1
| |||
Form 4
|
—
|
0
|
$16.91 | -$48,620.00 |
0
|
Nov 1
| |||
Form 4
|
—
|
0
|
$16.59 | -$47,212.00 |
0
|
Oct 2
| |||
Form 4
|
—
|
0
|
$19.49 | -$100,067.00 |
0
|
Sep 1 - Sep 6
| |||
Form 4
|
—
|
0
|
$18.27 | -$67,689.75 |
0
|
Aug 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
$17.45 | -$435,723.05 |
0
|
Aug 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
$14.13 | -$113,616.00 |
0
|
Scheduled
|
Sep 2
| ||
Form 4
|
—
|
0
|
$14.02 | -$111,960.00 |
0
|
Scheduled
|
Jun 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
$15.35 | -$131,911.50 |
0
|
Scheduled
|
Apr 5
| ||
Form 4
|
—
|
0
|
$17.65 | -$110,936.50 |
0
|
Scheduled
|
Jan 19
| ||
Form 4
|
—
|
0
|
$12.11 | -$55,551.00 |
0
|
Scheduled
|
Oct 19
| ||
Form 4
|
—
|
0
|
$11.52 | -$49,661.00 |
0
|
Scheduled
|
Jul 17
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
—
|
0
|
$11.33 | -$47,750.00 |
0
|
Scheduled
|
May 22
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Jazz Pharmaceuticals plc (JAZZ) Snapshot price: $107.14
President and COO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +17.09% | 8.03K |
$142.78 | -$774,724.28 | 55.01K |
Mar 3 - Mar 5
| |||
Form 4
| -18.22% | -10.46K |
—
|
—
| 46.98K |
Dec 5
| |||
Form 4
| +17.93% | 8.71K |
$153.96 | -$739,315.92 | 57.25K |
Mar 3 - Mar 5
| |||
Form 4
| -3.24% | -1.62K |
$131.01 | -$212,760.24 | 48.55K |
Jan 3
| |||
Form 4
| -6.93% | -3.72K |
$164.75 | -$612,540.50 | 49.96K |
Mar 5
| |||
Form 4
| +27.86% | 11.7K |
—
|
—
| 53.68K |
Feb 25
| |||
Form 4
| -3.69% | -1.61K |
$160.40 | -$257,762.80 | 41.98K |
Jan 4
| |||
Form 4
| -3.84% | -1.74K |
$124.50 | -$216,007.50 | 43.39K |
Mar 5
| |||
Form 4
| +54.93% | 16K |
—
|
—
| 45.13K |
Feb 27
| |||
Form 4
| -5.20% | -1.60K |
$146.09 | -$233,597.91 | 29.13K |
Jan 3
| |||
Form 4
| +84.79% | 14K |
—
|
—
| 30.51K |
Feb 28
| |||
Form 4
| -8.85% | -1.60K |
$126.01 | -$202,120.04 | 16.51K |
Jan 3
| |||
Form 4
|
∞
| 18K |
—
|
—
| 18K |
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CERUS CORP (CERS) Snapshot price: $2.04
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +37.37% | 40K |
$5.00 | $200,000.00 | 147.04K |
Jun 5
| |||
Form 4
| +2.39% | 2.5K |
$1.88 | $4,688.75 | 107.05K |
May 9
| |||
Form 4
| +61.97% | 40K |
$5.00 | $200,000.00 | 104.55K |
Jun 7
| |||
Form 4
| +4.39% | 5K |
$1.91 | $9,535.00 | 118.81K |
May 26
| |||
Form 4
|
—
|
0
|
$3.55 | -$9,000.00 | 113.81K |
Nov 10
| |||
Form 4
| +21.91% | 20.45K |
—
|
—
| 113.81K |
Jun 1
| |||
Form 4
|
—
|
0
|
$4.56 | -$43,653.03 | 93.35K |
Scheduled
|
Aug 4
| ||
Form 4
| +55.93% | 33.49K |
—
|
—
| 93.35K |
Jun 1 - Jun 2
| |||
Form 4
|
—
|
0
|
$4.33 | -$14,235.00 | 59.87K |
Scheduled
|
May 18
| ||
Form 4
|
—
|
0
|
$5.34 | -$48,797.00 | 59.87K |
Scheduled
|
Feb 16
| ||
Form 4
|
—
|
0
|
$4.58 | -$33,505.00 | 59.87K |
Scheduled
|
Nov 17
| ||
Form 4
| +30.40% | 13.96K |
—
|
—
| 59.87K |
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
| +2.23% | 1K |
$4.15 | $4,150.00 | 45.91K |
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
| +39.68% | 12.76K |
—
|
—
| 44.91K |
Jun 4
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| +160.64% | 19.82K |
—
|
—
| 32.15K |
Jun 5
| |||
Form 4
|
∞
| 12.34K |
—
|
—
| 12.34K |
Jun 6 - Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SUNESIS PHARMACEUTICALS INC (VIRX) Snapshot price: $0.2301
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 10
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 30
| |||
Form 4
| +44.33% | 81.86K |
$0.75 | -$41,756.25 | 266.52K |
Feb 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 30
| |||
Form 4
| +14.31% | 25K |
$1.01 | $25,250.00 | 199.74K |
Aug 24 - Aug 25
| |||
Form 4
| +16.38% | 45.6K |
$2.32 | $25,458.47 | 324.07K |
Jul 24
| |||
Form 4
| +11.44% | 18.06K |
$2.22 | -$27,248.28 | 175.82K |
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 4
|
—
|
0
|
$5.05 | -$29,550.00 | 154.07K |
Scheduled
|
Aug 27
| ||
Form 4
| +19.05% | 24.39K |
$2.09 | $50,973.01 | 152.41K |
May 16
| |||
Form 4
| +5.11% | 6.22K |
$6.55 | $40,767.20 | 128.02K |
Feb 28 - Feb 28
| |||
Form 4
| +25.75% | 25K |
$2.60 | $65,000.00 | 122.09K |
Jun 18
| |||
Form 4
| +16.26% | 13.16K |
$5.22 | -$39,792.06 | 94.12K |
Feb 28
| |||
Form 4
| +190.30% | 75.37K |
$1.74 | $35,193.24 | 74.52K |
Feb 29
| |||
Form 4
| +2.01% | 2.5K |
$1.14 | $2,849.75 | 127.18K |
Nov 28
| |||
Form 4
| +4.83% | 2.1K |
$1.18 | $2,478.00 | 45.62K |
Nov 21
| |||
Form 4
| +12.98% | 5K |
$1.99 | $9,936.00 | 43.52K |
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
| +146.58% | 22.9K |
$2.10 | -$27,852.30 | 38.52K |
Feb 28
| |||
Form 4
| +129.43% | 52.88K |
$0.49 | -$14,855.06 | 93.73K |
Jul 30
| |||
Form 4
|
∞
| 676.38K |
$0.28 | $131,033.93 | 676.38K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 13
| |||
Form 4
| +16.85% | 5K |
$4.27 | $21,340.00 | 34.66K |
Mar 21
| |||
Form 4
|
∞
| 17.9K |
$4.25 | $74,742.18 | 17.9K |
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Protagonist Therapeutics, Inc (PTGX) Snapshot price: $41.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||